Thromboembolism and bleeding in patients with atrial fibrillation and liver disease – A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease

Kamilla Steensig,Manan Pareek,Anne Lund Krarup,Peter Sogaard,Michael Maeng,Bhupendar Tayal,Christina Ji-Young Lee,Christian Torp-Pedersen,Gregory Yh Lip,Peter Holland-Fischer,Kristian Hay Kragholm

Clinics and Research in Hepatology and Gastroenterology（2022）

引用 5|浏览4

暂无评分

摘要

•Anticoagulation in liver disease and atrial fibrillation may reduce thromboembolic risk.•Anticoagulation in liver disease and atrial fibrillation is not associated with increased bleeding.•Only a minority of patients with liver disease and atrial fibrillation receive anticoagulation.

查看译文

关键词

Atrial fibrillation,Bleeding,Liver disease,Oral anticoagulants,Stroke,Thromboembolism

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要